Katelyn Boren
Nurse Practitioner · Tupelo, MSNPI 1740821941
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,754 of the $9,532 with a category attached, or 81.3%. It is spread thinly across 37 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $3,868 and has fallen 55.3% since, to $1,731 in 2025. Among nurse practitioner clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 307 payments — averaging $31.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$1K
- Pfizer$1K
- Sumitomo Pharma America, Inc.$707
- Medtronic$698
- Astellas Pharma US Inc$668
- Dendreon Pharmaceuticals LLC$664
- plus $4K from 31 others
What the payments were for
- Speaking & faculty fees$9009%
- Travel & lodging$7107%
- Food & beverage$7,75481%
- Education$1682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 20 | $1,403 |
| Pfizer | 9 | $1,029 |
| Sumitomo Pharma America, Inc. | 35 | $707 |
| Medtronic | 14 | $698 |
| Astellas Pharma US Inc | 35 | $668 |
| Dendreon Pharmaceuticals LLC | 19 | $664 |
| Axonics, Inc. | 11 | $460 |
| Bayer | 24 | $459 |
| Merck | 22 | $411 |
| Boston Scientific | 6 | $378 |
| Urogen Pharma, Inc. | 16 | $373 |
| Myovant Sciences Inc. | 18 | $275 |
| Johnson & Johnson | 14 | $270 |
| Procept Biorobotics Corporation | 2 | $255 |
| 180 Medical, Inc. | 7 | $182 |
| Cumberland Pharmaceuticals, Inc. | 3 | $178 |
| Cook Medical LLC | 1 | $143 |
| Myriad Genetic Laboratories, Inc. | 7 | $134 |
| Laborie Medical Technologies Corp. | 1 | $96 |
| Amgen | 4 | $80 |
| Novartis | 3 | $70 |
| Tolmar, Inc. | 4 | $67 |
| AbbVie | 4 | $59 |
| Endo Pharmaceuticals Inc. | 4 | $58 |
| Rochester Medical Corporation | 2 | $45 |
| Verity Pharmaceuticals Inc. | 3 | $45 |
| Urovant Sciences Inc | 3 | $44 |
| AstraZeneca | 3 | $41 |
| Immunitybio, Inc. | 2 | $38 |
| Ferring Pharmaceuticals Inc. | 2 | $34 |
| Halozyme Inc | 2 | $32 |
| Tolmar Pharmaceuticals, Inc. | 2 | $31 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Blue Earth Diagnostics | 1 | $24 |
| Hollister Incorporated | 1 | $19 |
| Endo USA, Inc. | 1 | $19 |
| Calyxo, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift System$932
- ORGOVYX$900
- INTERSTIM$390
- PROVENGE$262
- AquaBeam Robotic System$255
- Caldolor$150
- Cook$143
- Lumenis Pulse 120H$125
- JELMYTO$117
- Bulkamid$117
- Axonics$117
- UroLift$100
How this compares
$9,532 in reported general payments places this provider in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 132 | $78,177 |
| GemtesaVibegron | 69 | $40,448 |
| Tamsulosin Hcl | 285 | $3,358 |
| Methenamine Hippurate | 63 | $2,867 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 94 | $1,492 |
| Estradiol | 25 | $1,176 |
| Tolterodine Tartrate | 12 | $1,117 |
| Doxycycline Hyclate | 45 | $963 |
| Silodosin | 25 | $889 |
| Trospium Chloride | 43 | $824 |
| Finasteride | 53 | $673 |
| Dutasteride | 13 | $667 |
| Cephalexin | 128 | $627 |
| Trimethoprim | 12 | $527 |
| Oxybutynin Chloride ErOxybutynin Chloride | 28 | $374 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $668 | $78,177132 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $707 | $40,44869 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Other nurse practitioner in Tupelo
- Stephanie AtkinsonTupelo$7K
- Meagan HillhouseTupelo$7K
- Janice DriskellTupelo$6K
- Christina TreppendahlRidgeland$125K
- Jo Anna WarrenJackson$73K
- Marisa StringerBiloxi$68K
- Sara KlausFlowood$48K
- Micaela PerkinsOxford$32K
- Michelle TharpJackson$28K
- Kaylon LewisHattiesburg$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.